Invermis Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Invermis General Information
Description
Operator of a biotechnology company intended to provide transgenics services. The company specializes in areas such as neurodegenerative disease and innate immunity treatments.
Contact Information
Website
www.invermis.comOwnership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- 222 Wimbledon Park Road
- London SW18 5RL
- England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Acquirer
Vertical(s)
Corporate Office
- 222 Wimbledon Park Road
- London SW18 5RL
- England, United Kingdom
Invermis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Invermis FAQs
-
When was Invermis founded?
Invermis was founded in 2019.
-
Where is Invermis headquartered?
Invermis is headquartered in London, United Kingdom.
-
What industry is Invermis in?
Invermis’s primary industry is Biotechnology.
-
Is Invermis a private or public company?
Invermis is a Private company.
-
What is Invermis’s current revenue?
The current revenue for Invermis is .
-
When was Invermis acquired?
Invermis was acquired on 15-May-2020.
-
Who acquired Invermis?
Invermis was acquired by Magnitude Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
